Page 49 - CIBEROBN2016-ENG

Most relevant scientific articles
• Estruch R., Martínez-González M.A., Corella D., Salas-Salvadó J., Fito M., Chiva-Blanch G. et
al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: A prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. The Lancet Diabetes and Endocrinology. 2016.
• Casas R, Sacanella E, Urpí-Sardà M, Corella D, Castañer O, Lamuela-Raventós RM et al. Long-Term Immunomodulatory Effects of a Mediterranean Diet in Adults at High Risk of Cardiovascular Disease in the PREvención con DIeta MEDiterránea (PREDIMED) Randomized Controlled Trial.The Journal of nutrition. 2016;146(9):1684-93.
• Ruiz-Canela M., Toledo E., Clish C.B., Hruby A., Liang L., Salas-Salvadó J. et al. Plasma branched- chain amino acids and incident cardiovascular disease in the PREDIMED Trial. Clinical Chemistry. 2016;62(4):582-592.
• Guasch-Ferre M., Zheng Y., Ruiz-Canela M., Hruby A., Martínez-González M.A., Clish C.B. et al. Plasma acylcarnitines and risk of cardiovascular disease: Effect of Mediterranean diet interventions. American Journal of Clinical Nutrition. 2016;103(6):1408-1416.
• Sala-Vila A., Díaz-López A., Valls-Pedret C., Cofan M., García-Layana A., Lamuela-Raventós R.-M. et al. Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial. JAMA Ophthalmology. 2016;134(10):1142-1149.
Hightlights
Currently, we participate in the PREDIMED Plus study; it would assess the effect on adiposity, cardiovascular risk factors and quality of life of an intensive weight loss intervention based on a low calorie Mediterranean diet, physical activity and behavioral therapy, the effects of the Mediterranean diet on the primary prevention of cardiovascular disease, now framed in the CIBEROBN. In parallel, we are carrying out a
study to reduce body weight with a natural plant extracts, participate in the InterCIBER INFLAMES Project and designing a new randomized parallel group controlled intervention trial on the protective effects
of moderate alcohol consumption on cardiovascular disease (MACH 14 trial) that will have included 20 centers from USA, Europe, Africa, Australia and South America. Also, we participate in collaboration with the Department of Nutrition and Food Science School of Pharmacy of University of Barcelona in a study to know the nutritional benefits of following diet based on ecological products, so as a study to know the alcohol benefits on menopausal women and osteoporosis disease. On the other side, our group
has published over 150 research papers in journals such as New England Journal of Medicine, Annals of Internal Medicine, JAMA, Archives of Medicine, Annals of Neurology and Archives of Neurology, American Journal of Clinical Nutrition and the Journal of Nutrition or Lancet Diabetes Endocrinol.
OBN
Research groups 49